Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
HCA's Cash to Debt is ranked higher than
50% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. HCA: 0.02 )
HCA' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.02

Equity to Asset -0.25
HCA's Equity to Asset is ranked lower than
52% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. HCA: -0.25 )
HCA' s 10-Year Equity to Asset Range
Min: -0.5   Max: 0.42
Current: -0.25

-0.5
0.42
Interest Coverage 1.59
HCA's Interest Coverage is ranked higher than
56% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 5.04 vs. HCA: 1.59 )
HCA' s 10-Year Interest Coverage Range
Min: 1.32   Max: 5.7
Current: 1.59

1.32
5.7
F-Score: 9
Z-Score: 2.01
M-Score: -2.70
WACC vs ROIC
7.99%
11.60%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.58
HCA's Operating margin (%) is ranked higher than
79% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 9.13 vs. HCA: 9.58 )
HCA' s 10-Year Operating margin (%) Range
Min: 5.48   Max: 15.86
Current: 9.58

5.48
15.86
Net-margin (%) 4.91
HCA's Net-margin (%) is ranked higher than
76% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 4.95 vs. HCA: 4.91 )
HCA' s 10-Year Net-margin (%) Range
Min: -1.62   Max: 8.3
Current: 4.91

-1.62
8.3
ROA (%) 6.04
HCA's ROA (%) is ranked higher than
83% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 3.91 vs. HCA: 6.04 )
HCA' s 10-Year ROA (%) Range
Min: -1.41   Max: 9.71
Current: 6.04

-1.41
9.71
ROC (Joel Greenblatt) (%) 20.70
HCA's ROC (Joel Greenblatt) (%) is ranked higher than
80% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 18.78 vs. HCA: 20.70 )
HCA' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 8.76   Max: 40.76
Current: 20.7

8.76
40.76
Revenue Growth (3Y)(%) 4.90
HCA's Revenue Growth (3Y)(%) is ranked higher than
70% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 7.20 vs. HCA: 4.90 )
HCA' s 10-Year Revenue Growth (3Y)(%) Range
Min: -7.8   Max: 24.3
Current: 4.9

-7.8
24.3
EBITDA Growth (3Y)(%) 2.50
HCA's EBITDA Growth (3Y)(%) is ranked higher than
69% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. HCA: 2.50 )
HCA' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.9   Max: 39.3
Current: 2.5

-9.9
39.3
EPS Growth (3Y)(%) 6.90
HCA's EPS Growth (3Y)(%) is ranked higher than
73% of the 191 Companies
in the Global Medical Care industry.

( Industry Median: 10.90 vs. HCA: 6.90 )
HCA' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 88.4
Current: 6.9

0
88.4
» HCA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

HCA Guru Trades in Q1 2014

Mario Gabelli 15,000 sh (New)
Pioneer Investments 208,563 sh (New)
Steven Cohen 32,203 sh (+100.09%)
Paul Tudor Jones 17,349 sh (+21.94%)
David Tepper 5,326,882 sh (+4.42%)
Leon Cooperman 2,603,500 sh (+2.82%)
Caxton Associates 150,000 sh (unchged)
Vanguard Health Care Fund 6,746,600 sh (unchged)
Larry Robbins 12,841,713 sh (unchged)
John Griffin Sold Out
Andreas Halvorsen Sold Out
John Paulson 3,402,619 sh (-0.04%)
Manning & Napier Advisors, Inc 837,125 sh (-1.9%)
Lee Ainslie 4,876,540 sh (-4.2%)
David Dreman 1,025 sh (-12.91%)
Jeremy Grantham 44,100 sh (-61.82%)
Joel Greenblatt 33,554 sh (-75.86%)
Caxton Associates 90,000 sh (-90%)
Louis Moore Bacon 8,382 sh (-93.29%)
» More
Q2 2014

HCA Guru Trades in Q2 2014

Jim Simons 416,000 sh (New)
Stanley Druckenmiller 194,600 sh (New)
Jean-Marie Eveillard 2,964,059 sh (New)
Louis Moore Bacon 94,340 sh (+1025.51%)
Mario Gabelli 35,000 sh (+133.33%)
Pioneer Investments 291,555 sh (+39.79%)
Lee Ainslie 5,990,122 sh (+22.84%)
Caxton Associates 100,000 sh (+11.11%)
John Paulson 3,402,619 sh (unchged)
Vanguard Health Care Fund 6,746,600 sh (unchged)
David Tepper 5,326,882 sh (unchged)
Caxton Associates 100,000 sh (unchged)
Manning & Napier Advisors, Inc Sold Out
Jeremy Grantham Sold Out
David Dreman Sold Out
Leon Cooperman 2,544,700 sh (-2.26%)
Paul Tudor Jones 16,276 sh (-6.18%)
Larry Robbins 11,862,642 sh (-7.62%)
Joel Greenblatt 25,218 sh (-24.84%)
» More
Q3 2014

HCA Guru Trades in Q3 2014

Ken Heebner 1,795,000 sh (New)
Steven Cohen 102,600 sh (New)
Andreas Halvorsen 1,794,780 sh (New)
Paul Tudor Jones 262,488 sh (+1512.73%)
Pioneer Investments 549,841 sh (+88.59%)
John Paulson 6,069,600 sh (+78.38%)
Louis Moore Bacon 147,531 sh (+56.38%)
Jean-Marie Eveillard 3,171,122 sh (+6.99%)
David Tepper 5,326,882 sh (unchged)
Mario Gabelli 35,000 sh (unchged)
Jim Simons Sold Out
Stanley Druckenmiller Sold Out
Leon Cooperman 2,441,700 sh (-4.05%)
Vanguard Health Care Fund 5,665,000 sh (-16.03%)
Larry Robbins 9,610,559 sh (-18.98%)
Lee Ainslie 4,157,133 sh (-30.6%)
Caxton Associates 25,000 sh (-75%)
Joel Greenblatt 3,699 sh (-85.33%)
» More
Q4 2014

HCA Guru Trades in Q4 2014

Vanguard Health Care Fund 6,143,500 sh (+8.45%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Heebner 2014-09-30 New Buy3.6%$54.52 - $73.48 $ 70.87%1795000
Lee Ainslie 2014-09-30 Reduce -30.6%1.47%$54.52 - $73.48 $ 70.87%4157133
John Paulson 2014-09-30 Add 78.38%0.79%$54.52 - $73.48 $ 70.87%6069600
Andreas Halvorsen 2014-09-30 New Buy0.51%$54.52 - $73.48 $ 70.87%1794780
Vanguard Health Care Fund 2014-09-30 Reduce -16.03%0.16%$54.52 - $73.48 $ 70.87%5665000
Joel Greenblatt 2014-09-30 Reduce -85.33%0.02%$54.52 - $73.48 $ 70.87%3699
Lee Ainslie 2014-06-30 Add 22.84%0.89%$48.21 - $58.01 $ 70.834%5990122
Jean-Marie Eveillard 2014-06-30 New Buy0.4%$48.21 - $58.01 $ 70.834%2964059
Mario Gabelli 2014-06-30 Add 133.33%0.01%$48.21 - $58.01 $ 70.834%35000
Joel Greenblatt 2014-06-30 Reduce -24.84%0.01%$48.21 - $58.01 $ 70.834%25218
David Dreman 2014-06-30 Sold Out $48.21 - $58.01 $ 70.834%0
John Griffin 2014-03-31 Sold Out 1.5%$47.19 - $51.69 $ 70.843%0
Andreas Halvorsen 2014-03-31 Sold Out 0.59%$47.19 - $51.69 $ 70.843%0
Lee Ainslie 2014-03-31 Reduce -4.2%0.13%$47.19 - $51.69 $ 70.843%4876540
David Tepper 2014-03-31 Add 4.42%0.13%$47.19 - $51.69 $ 70.843%5326882
Joel Greenblatt 2014-03-31 Reduce -75.86%0.12%$47.19 - $51.69 $ 70.843%33554
Mario Gabelli 2014-03-31 New Buy$47.19 - $51.69 $ 70.843%15000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about HCA Holdings Inc

These 10 Stocks Are Likely To Outperform
Using the GuruFocus All-In-One Screener, I searched for large cap stocks with the highest Piotroski F-Score of 9. The Piotroski F-Score is a system based on the fundamentals of a company. It was developed by Joseph Piotroski who earned his Ph.D. in accounting from the University of Michigan and is now an associate professor of accounting at the Stanford University Graduate School of Business. Read more...
Weekly Insider Sells Highlight: HCA, MCK, P, ROP
According to GuruFocus Insider Data, the largest insider sells during the past week were: HCA Holdings Inc., McKesson Corp, Pandora Media Inc. and Roper Industries Inc. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 18.10
HCA's P/E(ttm) is ranked higher than
92% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 44.30 vs. HCA: 18.10 )
HCA' s 10-Year P/E(ttm) Range
Min: 3.87   Max: 19.7
Current: 18.1

3.87
19.7
Forward P/E 12.39
HCA's Forward P/E is ranked higher than
94% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 25.38 vs. HCA: 12.39 )
N/A
PE(NRI) 18.10
HCA's PE(NRI) is ranked higher than
91% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 43.00 vs. HCA: 18.10 )
HCA' s 10-Year PE(NRI) Range
Min: 3.87   Max: 19.72
Current: 18.1

3.87
19.72
P/S 0.89
HCA's P/S is ranked higher than
82% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.65 vs. HCA: 0.89 )
HCA' s 10-Year P/S Range
Min: 0.32   Max: 0.94
Current: 0.89

0.32
0.94
PFCF 16.31
HCA's PFCF is ranked higher than
87% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 45.47 vs. HCA: 16.31 )
HCA' s 10-Year PFCF Range
Min: 4.08   Max: 17.24
Current: 16.31

4.08
17.24
POCF 7.94
HCA's POCF is ranked higher than
90% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 17.44 vs. HCA: 7.94 )
HCA' s 10-Year POCF Range
Min: 2.57   Max: 8.39
Current: 7.94

2.57
8.39
EV-to-EBIT 17.37
HCA's EV-to-EBIT is ranked higher than
83% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 22.61 vs. HCA: 17.37 )
HCA' s 10-Year EV-to-EBIT Range
Min: 8.1   Max: 18.8
Current: 17.37

8.1
18.8
PEG 6.03
HCA's PEG is ranked higher than
87% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HCA: 6.03 )
HCA' s 10-Year PEG Range
Min: 0.37   Max: 0.97
Current: 6.03

0.37
0.97
Shiller P/E 17.37
HCA's Shiller P/E is ranked higher than
95% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 90.55 vs. HCA: 17.37 )
HCA' s 10-Year Shiller P/E Range
Min: 5.36   Max: 18.34
Current: 17.37

5.36
18.34
Current Ratio 1.51
HCA's Current Ratio is ranked higher than
79% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 1.32 vs. HCA: 1.51 )
HCA' s 10-Year Current Ratio Range
Min: 0.81   Max: 1.9
Current: 1.51

0.81
1.9
Quick Ratio 1.29
HCA's Quick Ratio is ranked higher than
75% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 1.19 vs. HCA: 1.29 )
HCA' s 10-Year Quick Ratio Range
Min: 0.71   Max: 1.68
Current: 1.29

0.71
1.68
Days Inventory 70.67
HCA's Days Inventory is ranked higher than
71% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 40.60 vs. HCA: 70.67 )
HCA' s 10-Year Days Inventory Range
Min: 20.43   Max: 69.24
Current: 70.67

20.43
69.24
Days Sales Outstanding 55.82
HCA's Days Sales Outstanding is ranked higher than
68% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 49.96 vs. HCA: 55.82 )
HCA' s 10-Year Days Sales Outstanding Range
Min: 44.84   Max: 56.78
Current: 55.82

44.84
56.78

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 3.91
HCA's Price/DCF (Projected) is ranked higher than
74% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 3.42 vs. HCA: 3.91 )
HCA' s 10-Year Price/DCF (Projected) Range
Min: 3.46   Max: 21.43
Current: 3.91

3.46
21.43
Price/Median PS Value 1.68
HCA's Price/Median PS Value is ranked higher than
61% of the 328 Companies
in the Global Medical Care industry.

( Industry Median: 1.27 vs. HCA: 1.68 )
HCA' s 10-Year Price/Median PS Value Range
Min: 0.67   Max: 1.7
Current: 1.68

0.67
1.7
Earnings Yield (Greenblatt) 5.80
HCA's Earnings Yield (Greenblatt) is ranked higher than
82% of the 307 Companies
in the Global Medical Care industry.

( Industry Median: 4.80 vs. HCA: 5.80 )
HCA' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.3   Max: 12.3
Current: 5.8

5.3
12.3
Forward Rate of Return (Yacktman) -10.81
HCA's Forward Rate of Return (Yacktman) is ranked higher than
56% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 11.08 vs. HCA: -10.81 )
HCA' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -13.7   Max: 47.7
Current: -10.81

-13.7
47.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 165 hospitals, comprised of 159 general, acute care hospitals; five psychiatric hospitals; and one rehabilitation hospital. In addition, it operated 115 freestanding surgery centers. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.
» More Articles for HCA

Headlines

Articles On GuruFocus.com
David Tepper's Top 4 Holdings: GM, C, PCLN and HCA Nov 25 2014 
These 10 Stocks Are Likely To Outperform Jun 17 2014 
Weekly Insider Sells Highlight: HCA, MCK, P, ROP Jun 02 2014 
Highest Paid Guru David Tepper Reports Appaloosa Management’s Top Five Fourth Quarter Stocks Feb 17 2014 
Manning & Napier New Stocks of Fourth Quarter Jan 29 2014 
King of Consistency - Larry Robbins’ High Conviction Stocks in Review Dec 31 2013 
David Tepper’s Top Five Held Stocks Nov 20 2013 
Investing in Healthcare in the ObamaCare Era Sep 25 2013 
Steven Cohen's Top Q2 Stock Increases Aug 15 2013 
comment on HCA Mar 13 2013 

More From Other Websites
HCA 4th Quarter 2014 Earnings Conference Call Jan 30 2015
HCA 4th Quarter 2014 Earnings Conference Call Jan 30 2015
HCA Appoints Sam Hazen Chief Operating Officer Jan 30 2015
HCA Appoints Sam Hazen Chief Operating Officer Jan 30 2015
9:00 am HCA announces the appointment of Sam Hazen as the company's COO, effective immediately Jan 30 2015
Obama's 'precision medicine' initiative gets Bay Area face Jan 29 2015
Putting Precision Medicine For Cancer At Work In America's Largest Hospital Jan 29 2015
LifePoint Hospitals fundamentals should appeal to investors Jan 28 2015
Taking Stock: Winners and Losers, Stock of the Day Jan 26 2015
HCA Holdings (HCA) Stock Is Up Today Ahead of S&P 500 Inclusion Jan 26 2015
HCA Holdings to Replace Safeway on S&P 500 Jan 23 2015
HCA Holdings Set to Join the S&P 500 Jan 23 2015
Notable option trades in equities Jan 22 2015
Traders give HCA vote of confidence Jan 22 2015
The consumer as 'disruptor' and other trends to watch from the Nashville Health Care Council's Wall... Jan 21 2015
CHS' Wayne Smith, analysts on the Obamacare subsidy case and the Supreme Court Jan 21 2015
Community Health Systems Reports Preliminary Q4 Results - Analyst Blog Jan 21 2015
Adeptus (ADPT) Falls: Stock Goes Down 6.7% - Tale of the Tape Jan 21 2015
Will Intuitive Surgical (ISRG) Disappoint Earnings in Q4? - Analyst Blog Jan 20 2015
Will Quality Systems (QSII) Surprise Earnings this Quarter? - Analyst Blog Jan 20 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK